Skip to main content
. 2018 Oct 12;11:6871–6877. doi: 10.2147/OTT.S182034

Figure 2.

Figure 2

The prognosis of miR-638 in breast cancer.

Note: Patients with low miR-638 expression showed shorter overall survival than those with high expression levels.